Biotech Values

[ghmm]

CELGZ:

I am just now getting to doing more research on the CVR and see it can be extremely lucrative if things go right!

Peter, do you happen to know if the Phase 2 Pancreatic results were published?

Pancreatic cancer seems to be a high risk area. I don't do much oncology investing and am just getting familiar with Abraxane. I see its supposed to penetrate the stoma to reach the tumor. My limited knowledge of Pancreatic cancer comes from Halozyme and they have talked a lot about that being a major obstacle to treatment of pancreatic cancer. There was a nice article a while back with some animal data talking about how their PEG-PH20 was able to do that and show a substantial benefit.